Theaprin Pharmaceuticals, Inc. v. Conway

137 A.D.3d 1256, 27 N.Y.S.3d 397
Procedural entryThis page is a short order in Theaprin Pharmaceuticals, Inc. v. Conway. Read the opinion of the Court — 137 A.D.3d 1254
Appellate Division of the Supreme Court of the State of New York·Decided March 30, 2016·No. 2014-02963·Published

Opinion

In an action, inter alia, to recover damages for breach of contract and fraud, the plaintiffs appeal, as limited by their brief, from so much of an order of the Supreme Court, Nassau County (Driscoll, J.), entered January 24, 2014, as granted the motion of the defendants Joseph D. Conway and Joseph D. Conway Certified Public Accountant and the separate motion of the defendants Michael Conway and Diana Conway to dismiss the complaint pursuant to CPLR 3211 (a).

Ordered that the order is affirmed insofar as appealed from, with costs.

The allegations contained in the complaint in this action are substantially the same as those in the complaint in Theaprin Pharms., Inc. v Conway (137 AD3d 1254 [2016] [decided herewith]), and, for substantially the same reasons, the Supreme Court properly granted the defendants’ motions to dismiss the complaint pursuant to CPLR 3211 (a).

Dickerson, J.P., Hall, Austin and Sgroi, JJ., concur.

Free access — add to your briefcase to read the full text and ask questions with AI

Theaprin Pharmaceuticals, Inc. v. Conway, 137 A.D.3d 1256, 27 N.Y.S.3d 397 (N.Y. Ct. App. 2016).

137 A.D.3d 1256 (Theaprin Pharmaceuticals, Inc. v. Conway) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Theaprin Pharmaceuticals, Inc. v. Conway
137 A.D.3d 1254 (Appellate Division of the Supreme Court of New York, 2016)